nocodazole has been researched along with nutlin-3a in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apontes, P; Blagosklonny, MV; Demidenko, ZN; Leontieva, OV; Li, F | 1 |
| Blagosklonny, MV | 1 |
| Blagosklonny, MV; Demidenko, ZN; Gudkov, AV; Leontieva, OV | 1 |
| Baer, C; Breyssens, H; Brown, NR; Caballero, OL; Cebon, J; Endicott, J; Goding, CR; Hu, Y; John, T; Jones, EY; Kessler, BM; Knapp, S; Lu, M; Lu, X; Middleton, MR; Ratnayaka, I; Salter, V; Siebold, C; Sullivan, A; Sviderskaya, EV; Zhong, S | 1 |
4 other study(ies) available for nocodazole and nutlin-3a
| Article | Year |
|---|---|
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cytoprotection; Epithelial Cells; Fibroblasts; G1 Phase; Humans; Imidazoles; Metformin; Nocodazole; Paclitaxel; Piperazines; Sirolimus; Tumor Suppressor Protein p53 | 2011 |
The power of chemotherapeutic engineering: arresting cell cycle and suppressing senescence to protect from mitotic inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Humans; Imidazoles; Isopropyl Thiogalactoside; Mitosis; Nocodazole; Piperazines; Sirolimus; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2011 |
Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Shape; Cellular Senescence; Humans; Imidazoles; Isopropyl Thiogalactoside; Nocodazole; Piperazines; Sirolimus | 2011 |
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin B1; Dimerization; Humans; Imidazoles; Indoles; Intracellular Signaling Peptides and Proteins; M Phase Cell Cycle Checkpoints; Melanoma; Mice; Neoplasm Metastasis; Nocodazole; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-mdm2; Repressor Proteins; Sulfonamides; Triazoles; Tumor Suppressor Protein p53; Vemurafenib; Xenograft Model Antitumor Assays | 2013 |